Teriparatide is a pharmaceutical ingredient whose molecular pharmacology encompasses primary target interactions, off-target binding to safety-relevant proteins, and concentration-response relationships that collectively determine whether pharmacologically-based or NOAEL-based OEL derivation methodology is more protective for occupationally exposed workers. The identification of the critical pharmacodynamic effect and its dose-response threshold in humans—from clinical pharmacology studies or clinical pharmacokinetic-pharmacodynamic modelling—provides a scientifically superior basis for OEL derivation compared to default interspecies extrapolation from animal toxicity data.
Occupational exposure monitoring for Teriparatide validates that engineering controls achieve the OEL in worker breathing zones during manufacturing, dispensing, and sampling operations. Personal air sampling during representative manufacturing tasks—including powder dispensing, granulation, tableting, and equipment cleaning—provides the primary me
